The Benefits of Telephone Follow-up (TFU) (TFU)

August 4, 2022 updated by: Alana Prejet, Brandon University

The Benefits of Telephone Follow-Up After a Mental Health Assessment in an Emergency Department

This study will investigate the impact of a brief telephone follow-up following a mental health assessment in the emergency department. The purpose of the telephone call will be to provide psycho-education, clarify any questions and reinforce discharge planning.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This is a randomized controlled trial. The experimental group will receive a phone call within 72 hours of discharge to provide psycho education, clarify any questions they may have and to reinforce discharge plans made in the ED. The control group will not receive this phone call. Within 30 days of discharge, both groups will receive a phone call to collect data on treatment compliance including medication and follow-up adherence and if any additional visits to the Emergency Department were necessary.

Study Type

Interventional

Enrollment (Anticipated)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Manitoba
      • Winnipeg, Manitoba, Canada, R2H 2A6
        • Recruiting
        • St. Boniface Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria

  • Discharged from the ED
  • Age of majority
  • Competent.

Exclusion Criteria

  • Incompetent,
  • Under 18
  • Admitted to the hospital

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Control
Post-test satisfaction
Telephone Follow-up within 72 hours to discuss psycho education, discharge planning and clarify any questions they may have.
Experimental: Experimental
Treatment and satisfaction
Telephone Follow-up within 72 hours to discuss psycho education, discharge planning and clarify any questions they may have.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Emergency Department readmission rates
Time Frame: 30 days.
Does a telephone call reduce readmission rates?
30 days.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction with care in the Emergency Department using a 7 point Likert Scale as a function of the telephone follow up.
Time Frame: 30 days.
Various measures of satisfaction in care provided in Emergency Department. Higher scores indicate higher satisfaction.
30 days.
Adherence to pharmacological interventions and follow-up appointments.
Time Frame: 30 days.
Adhering to pharmacological interventions and follow-up appointments by self rating on a 7 point Likert Scale. Higher scores indicate greater adherence to treatment adherence.
30 days.
Understanding of Treatment plan
Time Frame: 30 days.
Assessing if the participant believes they have a good understanding of their care plan by self rating on a 7 point Likert Scale. Higher scores indicate greater understanding of treatment plan.
30 days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alana E Prejet, BScPN, BA, Brandon University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 2, 2022

Primary Completion (Anticipated)

August 1, 2023

Study Completion (Anticipated)

August 1, 2023

Study Registration Dates

First Submitted

February 23, 2021

First Submitted That Met QC Criteria

March 9, 2021

First Posted (Actual)

March 11, 2021

Study Record Updates

Last Update Posted (Actual)

August 8, 2022

Last Update Submitted That Met QC Criteria

August 4, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • BrandonU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health Issue

Clinical Trials on Telephone Follow-up

3
Subscribe